KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Non-Current Liabilities: 2018-2023

Historic Other Non-Current Liabilities for Castle Biosciences (CSTL) over the last 5 years, with Dec 2023 value amounting to $25,000.

  • Castle Biosciences' Other Non-Current Liabilities was N/A to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $25,000 for FY2023, which is 72.22% down from last year.
  • Castle Biosciences' Other Non-Current Liabilities amounted to $25,000 in FY2023, which was down 72.22% from $90,000 recorded in FY2022.
  • Over the past 5 years, Castle Biosciences' Other Non-Current Liabilities peaked at $18.3 million during FY2021, and registered a low of $25,000 during FY2023.
  • Its 3-year average for Other Non-Current Liabilities is $6.1 million, with a median of $90,000 in 2022.
  • Per our database at Business Quant, Castle Biosciences' Other Non-Current Liabilities soared by 1,682.36% in 2021 and then crashed by 99.51% in 2022.
  • Yearly analysis of 4 years shows Castle Biosciences' Other Non-Current Liabilities stood at $1.0 million in 2020, then spiked by 1,682.36% to $18.3 million in 2021, then plummeted by 99.51% to $90,000 in 2022, then tumbled by 72.22% to $25,000 in 2023.